One possibility is that peripheral serum and blood biomarkers may not reflect the pathobiology within the central nervous system, (CNS), especially in neurodevelopmental disorders where there may not be significant ongoing neuronal damage.
← all excerpts
Editorial: Biomarkers to Enable Therapeutics Development in Neurodevelopmental Disorders.
1
—
—